James Muth
Clinical Cardiac Electrophysiology · Lawrenceburg, INNPI 1750586483
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (43.5%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 33 manufacturers reported payments, led by Biotronik Inc. at 47.5% of the total. Reporting peaked in 2019 at $24,205 and has fallen 81.5% since, to $4,484 in 2025.
Across 312 payments — averaging $155.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biotronik Inc.$23K
- Medtronic$12K
- Boston Scientific$7K
- Medical Device Business Services, Inc.$1K
- Biosense Webster, Inc.$1K
- Abbott$955
- plus $3K from 27 others
What the payments were for
- Speaking & faculty fees$13,30027%
- Travel & lodging$21,02643%
- Food & beverage$14,00729%
- Education$310%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biotronik Inc. | 70 | $22,980 |
| Medtronic(2 entities) | 76 | $11,679 |
| Boston Scientific | 55 | $7,424 |
| Medical Device Business Services, Inc. | 7 | $1,407 |
| Biosense Webster, Inc. | 18 | $1,224 |
| Abbott | 16 | $955 |
| Impulse Dynamics (USA) Inc. | 7 | $516 |
| ZOLL Respicardia, Inc. | 1 | $508 |
| Atricure, Inc. | 1 | $186 |
| Esperion Therapeutics, Inc. | 3 | $153 |
| Cardiva Medical, Inc. | 9 | $152 |
| Braemar Manufacturing, LLC | 1 | $151 |
| Cvrx, Inc. | 1 | $145 |
| Pfizer | 7 | $135 |
| Merck | 6 | $110 |
| Johnson & Johnson | 6 | $89 |
| Philips North America LLC | 1 | $79 |
| Amgen | 4 | $72 |
| Bayer | 4 | $56 |
| Novartis | 2 | $48 |
| E.r. Squibb & Sons, L.L.C. | 3 | $47 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $34 |
| Boehringer Ingelheim | 2 | $33 |
| Veryan Medical Incorporated | 1 | $30 |
| Scpharmaceuticals Inc. | 1 | $21 |
| Lexicon Pharmaceuticals, Inc. | 1 | $17 |
| Edwards Lifesciences | 1 | $17 |
| Novo Nordisk | 1 | $17 |
| Actelion Pharmaceuticals US, Inc. | 1 | $16 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $16 |
| Vital Connect, Inc | 1 | $16 |
| Stryker | 1 | $15 |
| GSK | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Farapulse$2,643
- Carto 3$2,396
- Arctic Front$1,588
- S-ICD System Magnet$1,154
- SelectSecure$914
- EnSite Precision Cardiac Mapping System$563
- remede System$508
- WATCHMAN Access System$414
- Micra$321
- Acticor 7 VR-T DX$321
- OPTIMIZER SMART SYSTEM$271
- BioMonitor$237
- PulseSelect$210
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$186
- AFFERA MAPPING SYSTEM$162
- Viva$158
- CryoConsole$152
- Cardiac Monitoring Suite$151
- Barostim Neo System$145
- EMBLEM MRI S-ICD$145
How this compares
$48,364 in reported general payments places this provider in the 75th percentile of 72 clinical cardiac electrophysiology providers in Indiana.
See all clinical cardiac electrophysiology providers in Indiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 194 | $189,510 |
| XareltoRivaroxaban | 11 | $18,499 |
| Midodrine Hcl | 21 | $2,572 |
| Flecainide Acetate | 47 | $1,958 |
| Amiodarone Hcl | 102 | $1,756 |
| Metoprolol Succinate | 145 | $1,692 |
| SotalolSotalol Hcl | 45 | $1,035 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 37 | $546 |
| Metoprolol Tartrate | 44 | $337 |
| Amlodipine Besylate | 31 | $192 |
| Losartan Potassium | 26 | $185 |
| Pantoprazole Sodium | 21 | $166 |
| Lisinopril | 25 | $162 |
| Rosuvastatin Calcium | 13 | $152 |
| Bisoprolol Fumarate | 15 | $121 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $135 | $189,510194 claims |
| Johnson & JohnsonXarelto | $89 | $18,49911 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 72 clinical cardiac electrophysiology providers in Indiana.
Other clinical cardiac electrophysiology in Lawrenceburg
- Eric PrystowskyIndianapolis$1.1M
- Chad BonhommeWestfield$925K
- Kevin TrulockIndianapolis$402K
- Sharath VipparthyIndianapolis$114K
- Jasen GilgeIndianapolis$93K
- Vincent KeatingIndianapolis$80K
- Christopher ReedIndianapolis$80K
- Marcelle StuckyIndianapolis$76K
- Joseph SzwedIndianapolis$67K
- Krishna MalineniIndianapolis$65K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.